Research Topics
| Lingling LiSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
On weighting approaches for missing dataLingling Li
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
Stat Methods Med Res 22:14-30. 2013..We then generalise to more complex settings. Our goal is to provide a conceptual overview of existing IPW approaches and illustrate the connections and differences among these approaches...
Propensity score-based sensitivity analysis method for uncontrolled confoundingLingling Li
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts 02215, USA
Am J Epidemiol 174:345-53. 2011....- A conditional maximized sequential probability ratio test for pharmacovigilanceLingling Li
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Ave, 6th Floor, Boston, MA 02215, USA
Stat Med 29:284-95. 2010..Our test incorporates the randomness and variability from both the historical data and the surveillance population. Evaluations of the statistical power for CMaxSPRT are presented under different scenarios... - Effect of vitamin D and inhaled corticosteroid treatment on lung function in childrenAnn Chen Wu
Center for Child Health Care Studies, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA 02215 5301, USA
Am J Respir Crit Care Med 186:508-13. 2012..Low vitamin D levels are associated with asthma and decreased airway responsiveness. Treatment with inhaled corticosteroids improves airway responsiveness and asthma control... - Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010Sharon K Greene
Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA
Am J Epidemiol 175:1100-9. 2012..1 cases per million doses, 95% confidence interval: -3.1, 5.4). Further evaluation to assess GBS risk following both vaccination and respiratory infection is warranted... - Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010Sharon K Greene
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
Pharmacoepidemiol Drug Saf 22:335-44. 2013..We assessed oseltamivir safety before and during the pandemic using biologically plausible risk intervals, particularly focusing on psychiatric events... - A conditional sequential sampling procedure for drug safety surveillanceLingling Li
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care, 133 Brookline Ave, 6th Floor, Boston, MA 02215, U S A
Stat Med 28:3124-38. 2009..We end with discussions... 
A comparison of goodness of fit tests for the logistic GEE modelScott Evans
Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard School of Public Health, 651 Huntington Avenue, Boston, MA 02115, USA
Stat Med 24:1245-61. 2005..We evaluate the performance of each of the statistics with respect to type I error rates and power in a simulation study. Guidance is provided regarding appropriate use of the statistics under various scenarios...- Outcomes after periodic use of inhaled corticosteroids in childrenAnn Chen Wu
Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Medical School, 133 Brookline Avenue, 6th Floor, Boston, MA 02215, USA
J Asthma 46:517-22. 2009..However, scant information exists on the clinical outcomes of children with asthma who are using inhaled corticosteroids on a periodic basis in real-world settings... - Predictors of symptoms are different from predictors of severe exacerbations from asthma in childrenAnn Chen Wu
Center for Child Health Care Studies, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA 02215 5301, USA
Chest 140:100-7. 2011..The goal of our study was (1) to assess the association of asthma symptoms with severe asthma exacerbations and (2) to compare predictors of persistent asthma symptoms and predictors of severe asthma exacerbations... - H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink projectGrace M Lee
Center for Child Health Care Studies, Department of Population Medicine, Children s Hospital Boston, Boston, Massachusetts, USA
Am J Prev Med 41:121-8. 2011..A robust influenza immunization program in the U.S. requires ongoing monitoring of potential adverse events associated with vaccination... - Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone systemSengwee Toh
Department of Population Medicine, Harvard Medical School, Boston, MA 02215, USA
Arch Intern Med 172:1582-9. 2012..We assessed the risk for angioedema associated with the use of angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), and the direct renin inhibitor aliskiren... - Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?Sengwee Toh
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
Pharmacoepidemiol Drug Saf 21:524-34. 2012..It is unclear whether the risk varies by patient characteristics. We conducted a study to address this question... - Development of a Pharmacogenetic Predictive Test in asthma: proof of conceptAnn Chen Wu
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215 5301, USA
Pharmacogenet Genomics 20:86-93. 2010..To assess the feasibility of developing a Combined Clinical and Pharmacogenetic Predictive Test, comprised of multiple single nucleotide polymorphisms (SNPs) that is associated with poor bronchodilator response (BDR)... - Repeatability of response to asthma medicationsAnn Chen Wu
Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston, Mass, USA
J Allergy Clin Immunol 123:385-90. 2009..Pharmacogenetic studies of drug response in asthma assume that patients respond consistently to a treatment but that treatment response varies across patients; however, no formal studies have demonstrated this...